Researcher biography

National Health and Medical Research Council Career Development Fellow at the University of Queensland and Pharmacist Consultant at the Royal Brisbane and Women's Hospital. Professor Roberts has led multiple international pharmacokinetic studies and holds roles on multiple guideline committees.   

Featured projects Duration
Exploring the impact of altered and variable antimicrobial pharmacokinetics on bacterial killing and emergence of bacterial resistance.
Continuous versus intermittent beta-lactams administration in critically ill patients with sepsis not receiving renal replacement therapy.
Antibiotic penetration into epithelial lining fluid of mechanically ventilated patients with VAP and CAP.
Therapeutic drug monitoring and dose personalisation of antimicrobials in mechanically ventilated patients with Gram-negative pneumonia.
Exploring population variability of antimicrobial epithelial lining fluid penetration in patients with VAP.
Development of clinical practice guidelines on antimicrobial dosing incorporating new knowledge generated by the CRE REDUCE.
SaMpling Antibiotics in Renal Replacement Therapy (SMARRT).
Dose optimisation of anti-infectives in patients post-lung transplant
Ex Vivo renal replacement therapy study to quantify the effect of differing RRT settings on antimicrobial clearance.  
Beta-lactam antibiotic dose optimisation in critically ill patients
Antimicrobial pharmacokinetics in patients with cystic fibrosis, lung and bone marrow transplant.
Dose optimisation of antifungals and antivirals in post-lung transplant patients
Pharmacokinetics of Flucloxacillin and Lincomycin in burns patients.
Using laboratory-based infection models to develop better antibiotic dosing regimens
Pharmacokinetics of antifungals in intensive care patients.
Anti-infective drugs
Pharmacokinetics of antimicrobials in critically ill obese patients
Sedatives and analgesics
Pharmacometric analysis of antimicrobial pharmacokinetics to propose novel and innovative dosing regimens.
Dose optimisation of anti-infective drugs in extracorporeal membrane oxygenation (ECMO) - co-sponsored by CRE ACTIONS
Therapeutic drug monitoring optimisation of antimicrobial exposures for critically ill, burns and transplant patients.